Preventive
Tripoli
About Preventive
Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $30.0M
- Last round: Series Unknown (Oct 2025)
- Website: preventive.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Market Research, Medical
Social Profiles
Canonical: https://fsome.com/organization/preventive-50511 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.